Literature DB >> 25440787

Individualizing treatment choices using quantitative methods.

Stuart J Pocock1, Gregg W Stone2, Roxana Mehran3, Tim C Clayton4.   

Abstract

Mesh：

Year:  2014        PMID： 25440787     DOI： 10.1016/j.ahj.2014.08.003

Source DB:  PubMed          Journal:  Am Heart J        ISSN： 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  3 in total

1.  The impact of kidney function in patients on antithrombotic therapy: a post hoc subgroup analysis focusing on recurrent bleeding events from the AFIRE trial.

Authors:  Kunihiko Matsui; Satoshi Yasuda; Koichi Kaikita; Masaharu Akao; Junya Ako; Tetsuya Matoba; Masato Nakamura; Katsumi Miyauchi; Nobuhisa Hagiwara; Kazuo Kimura; Atsushi Hirayama; Hisao Ogawa
Journal:  BMC Med       Date:  2022-02-25       Impact factor: 8.775

2.  Absolute Benefit of Adjuvant Endocrine Therapies for Premenopausal Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer: TEXT and SOFT Trials.

Authors:  Meredith M Regan; Prudence A Francis; Olivia Pagani; Gini F Fleming; Barbara A Walley; Giuseppe Viale; Marco Colleoni; István Láng; Henry L Gómez; Carlo Tondini; Graziella Pinotti; Karen N Price; Alan S Coates; Aron Goldhirsch; Richard D Gelber
Journal:  J Clin Oncol       Date:  2016-04-04       Impact factor: 44.544

3.  Personalising the decision for prolonged dual antiplatelet therapy: development, validation and potential impact of prognostic models for cardiovascular events and bleeding in myocardial infarction survivors.

Authors:  Laura Pasea; Sheng-Chia Chung; Mar Pujades-Rodriguez; Alireza Moayyeri; Spiros Denaxas; Keith A A Fox; Lars Wallentin; Stuart J Pocock; Adam Timmis; Amitava Banerjee; Riyaz Patel; Harry Hemingway
Journal:  Eur Heart J       Date:  2017-04-07       Impact factor: 35.855
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.